Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Infosys co-founder backs an Indian brain computing center

The healthcare burdens of aging populations have traditionally been a Western problem, but rising life expectancy in emerging markets has caused the pressures to spread around the world. In India, the co-founder of IT services firm Infosys has responded by funding a brain and computing research center to improve the health of the 100 million citizens aged over 60.

Abbott Labs cuts jobs at HQ and plans for plant closure in Puerto Rico

Abbott Laboratories is cutting jobs, with plans to whack a plant in Puerto Rico as well as laying off staff at its Chicago-area headquarters. The company just won't say how many jobs are on the chopping block.

AstraZeneca is cutting 168 jobs as it shutters an Indian R&D site

AstraZeneca is pulling the plug on an Indian research shop as part of its ongoing R&D re-think, planning to shed another 168 jobs as it moves away from neglected diseases and focuses on spaces with higher growth potential.

Low-cost ventilator maker OneBreath pulls in $3M to expand in emerging markets

OneBreath, a maker of low-cost ventilators founded by Stanford University engineers, pulled in 180 million rupees (almost $3 million) in a funding round that will help it expand in emerging markets such as India, Africa and Eastern Europe.

Indian clinical trials plummet 93% as local regs tighten up

Years of lax regulations helped India build a booming market for clinical trials, but a recent move to strengthen patient protections has deflated demand and last year saw just 19 studies get underway in the country, according to The Pharma Letter.

Actavis is selling a China plant as it unloads manufacturing capacity globally

Generic drug maker Actavis is unloading some of its manufacturing assets as it digests the big chunk of business it bit off with its Warner Chilcott merger last year. It has reached a deal to unload its piece of a manufacturing plant in China after last week deciding to sell 7 money-losing API plants in Europe. 

Report: Indian clinical trials fell 93% last year

Years of lax regulations helped India build a booming market for clinical trials, but a recent move to strengthen patient protections has deflated demand, and last year saw just 19 studies get underway in the country, The Pharma Letter reports.

ResearchDx pushes into the Middle East for diagnostics development

ResearchDx, one of the few outfits devoted to contract test making, has extended its operation to include the Middle East, a region the company said is home to a growing biotech market.

Covidien opens an Indian medical training center with a med tech focus

Covidien's efforts to move its device business overseas continue as the Irish company opened a medical training and education center in Mumbai, India.

Varian touts emerging markets as looming Medicare changes take a toll

Varian Medical Systems reported yesterday that revenues during its first fiscal quarter jumped 5% from the same period a year ago to $712 million, and net income rose 3% to $98 million. The company cited particularly strong demand for its oncology products, which include equipment for performing radiosurgery and software that physicians can use in treatment planning.